Cory Berkland is a Professor in the Department of Pharmaceutical Chemistry and in the Department of Chemical Engineering at The University of Kansas. He received MS and PhD degrees from the Department of Chemical and Biomolecular Engineering at the University of Illinois in Urbana-Champaign and a BS degree in Chemical Engineering from Iowa State University in Ames. His lab studies pharmaceuticals and biomaterials. Prof. Berkland is a co-founder of Orbis Biosciences, Savara Pharmaceuticals, Bond Biosciences and Orion BioScience. He is also a co-developer of several technologies with industrial partners. He has worked at Sofinnova Ventures and currently serves on multiple boards in the pharmaceutical industry.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)